|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.17/-0.16
|
企业价值
1.02B
|
资产负债 |
每股账面净值
0.13
|
现金流量 |
现金流量率
--
|
损益表 |
收益
4.61M
|
每股收益
0.02
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/03 14:19 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides. |